View More Recent Stories

Feb 23, 2016 07:00AM Novocure to Present at Cowen and Company 36th Annual Health Care Conference
Feb 12, 2016 07:03AM Novocure (NVCR) Announces Positive Coverage Decision for Optune by Anthem (ANTM)
Feb 12, 2016 07:00AM Anthem Inc. Issues Positive Coverage Decision For Optune in Newly Diagnosed Glioblastoma
Feb 8, 2016 04:39PM Novocure's (NVCR) Results from TTFields + Ttemozolomide Phase 3 in Newly Diagnosed GBM Will be Publish in ASCO Report
Feb 8, 2016 04:35PM Novocure’s Phase 3 Pivotal Trial Results in Newly Diagnosed Glioblastoma Selected For ASCO’s Clinical Cancer Advances 2016 Report
Feb 1, 2016 04:35PM Novocure to Report Fourth Quarter, Year-End Financial Results
Jan 19, 2016 04:36PM Novocure (NVCR) Plans Presentation of Positive Phase 2 PANOVA Data at ASCO GI
Jan 19, 2016 04:35PM Novocure Presents Phase 2 PANOVA Results at ASCO GI Suggesting Tumor Treating Fields Therapy Plus Chemotherapy may be Safe as First-Line Treatment and Improve Survival of Patients with Advanced Pancre
Jan 11, 2016 07:30AM Novocure Announces Preliminary 2015 Operating Statistics
Jan 7, 2016 04:19PM Novocure (NVCR) Announces Submission of PMA to Japanese PMDA for Optune
Jan 7, 2016 04:15PM Novocure Submits PMA Partial Amendment Application to Japanese Pharmaceuticals and Medical Devices Agency for Treatment of Newly Diagnosed Glioblastoma Patients
Jan 6, 2016 08:26AM Novocure (NVCR) Announces Filing of PMA Supplement with FDA for Optune System
Jan 6, 2016 08:24AM Novocure Files Premarket Approval Supplement Application With FDA for Second Generation Optune System
Jan 4, 2016 07:00AM Novocure to Participate in 34th Annual J.P. Morgan Healthcare Conference
Dec 15, 2015 11:05AM Novocure to Hold Webcast to Discuss JAMA Publication of EF-14 Phase 3 Clinical Trial Data
Dec 15, 2015 11:01AM Journal of the American Medical Association (JAMA) Publishes Pivotal Phase 3 Data for Optune Plus Temozolomide to Treat Newly Diagnosed Glioblastoma
Dec 14, 2015 07:00AM New Data on Tumor Treating Fields’ Anti-Mitotic Mechanism of Action Published in Scientific Reports
Dec 3, 2015 04:35PM Retrospective Analysis Shows Optune Safe in Glioblastoma Patients with Implanted Non-Programmable Shunts
Dec 2, 2015 07:00AM Preliminary Phase 2 Data Demonstrate Tumor Treating Fields is Safe in Patients with Brain Metastases Originating from Non-Small Cell Lung Cancer
Nov 20, 2015 04:01PM New Phase 3 Data show Optune in Combination with Second Line Chemotherapy is Superior to Second Line Chemotherapy Alone in Glioblastoma Patients at First Recurrence
Nov 17, 2015 07:05AM Novocure Announces Webcast to Discuss New EF-14 Clinical Trial Analyses and Tumor Treating Fields Presentations from SNO 2015
Nov 17, 2015 07:00AM Novocure Announces 18 Presentations on Tumor Treating Fields at SNO 2015 Including New Analyses of the EF-14 Newly Diagnosed Glioblastoma Clinical Trial Data
Oct 26, 2015 04:05PM Novocure Reports Third Quarter 2015 Operating and Financial Results
Oct 19, 2015 04:05PM NovoCure Limited Announces Closing of Partial Exercise of IPO Over-Allotment Option
Oct 16, 2015 05:04PM Novocure to Offer On Demand Optune Certification Training for the Radiation Oncology Community at ASTRO 2015
Oct 16, 2015 11:54AM Novocure to Report Third Quarter 2015 Financial Results on Monday, October 26
Oct 7, 2015 04:05PM NovoCure Limited Announces Closing of Initial Public Offering
Oct 5, 2015 08:05PM FDA Approves Optune in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
Oct 5, 2015 08:05PM ADDING MULTIMEDIA FDA Approves Optune in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
Oct 5, 2015 07:00AM Novocure Announces CE Mark and First Patient Use of Second Generation Optune System
Oct 2, 2015 06:00AM NovoCure Limited (Nasdaq: NVCR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO
Oct 2, 2015 06:00AM NovoCure Limited (Nasdaq: NVCR) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO
Oct 1, 2015 09:07PM NovoCure Limited Announces Launch of Initial Public Offering
View More Recent Stories